Merck & Co., Inc. (NYSE:MRK) This autumn 2024 Outcomes Convention Name February 4, 2025 9:00 AM ET
Firm Individuals
Peter Dannenbaum – Senior Vice President, Investor Relations
Rob Davis – Chairman and Chief Government Officer
Caroline Litchfield – Chief Monetary Officer
Dr. Dean Li – President of Merck Analysis Labs
Convention Name Individuals
Umer Raffat – Evercore ISI
Terence Flynn – Morgan Stanley
Luisa Hector – Berenberg
Mohit Bansal – Wells Fargo
Daina Graybosch – Leerink Companions
Geoff Meacham – Citi
Chris Schott – JPMorgan
Tim Anderson – Financial institution of America
Akash Tewari – Jefferies
Trung Huynh – UBS
Vamil Divan – Guggenheim
Courtney Breen – Bernstein
James Shin – Deutsche Financial institution
Operator
Thanks for standing by. Welcome to the Merck & Firm This autumn Gross sales and Earnings Convention Name. Right now, all individuals are in a listen-only mode till the question-and-answer session of at this time’s convention. [Operator Instructions] This name is being recorded. You probably have any objections, you could disconnect at the moment.
I might now like to show the decision over to Mr. Peter Dannenbaum, Senior Vice President, Investor Relations. Sir, you could start.
Peter Dannenbaum
Thanks, Shirley, and good morning, everybody. Welcome to Merck’s fourth quarter 2024 convention name. Talking on at this time’s name might be Rob Davis, Chairman and Chief Government Officer; Caroline Litchfield, Chief Monetary Officer; and Dr. Dean Li, President of Merck Analysis Labs.
Earlier than we get began, I would wish to level out that now we have gadgets in our GAAP outcomes akin to acquisition associated fees, restructuring prices and sure different gadgets that now we have excluded from our non-GAAP outcomes. There’s a reconciliation in our press launch.
I may even remind you that a few of the statements that we make at this time could also be thought-about ahead wanting statements inside the that means of the Protected
